Found: 87
Select item for more details and to access through your institution.
Response.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 19, p. 1418, doi. 10.1093/jnci/83.19.1418-a
- By:
- Publication type:
- Article
Multidrug Resistance in Acute Myeloid Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 10, p. 663
- By:
- Publication type:
- Article
Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 6, p. 124, doi. 10.3390/ph13060124
- By:
- Publication type:
- Article
Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2.
- Published in:
- Pharmaceuticals (14248247), 2016, v. 9, n. 1, p. 4, doi. 10.3390/ph9010004
- By:
- Publication type:
- Article
Evaluation of an alternative ruxolitinib dosing regimen in patients with myelofibrosis: an open-label phase 2 study.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0642-0
- By:
- Publication type:
- Article
Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 3, p. 1081, doi. 10.1172/JCI75821
- By:
- Publication type:
- Article
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 536, doi. 10.3390/jcm9020536
- By:
- Publication type:
- Article
Rheumatoid Arthritis and Pure Red Cell Aplasia.
- Published in:
- 1984
- By:
- Publication type:
- Case Study
Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Malignant histiocytosis occurring with acute myelogenous leukemia in a patient with longstanding polycythemia vera.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Malignant histiocytoses developing in patients with B-cell lymphomas. Report of two cases.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Macrophage activation syndrome after granulocyte colony‐stimulating factor in a patient with systemic lupus erythematosus.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 747, doi. 10.1111/bjh.19262
- By:
- Publication type:
- Article
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study*.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 5, p. 832, doi. 10.1111/bjh.17336
- By:
- Publication type:
- Article
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 881, doi. 10.1111/bjh.16261
- By:
- Publication type:
- Article
An unusual presentation of paroxysmal nocturnal haemoglobinuria.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 3, p. 347, doi. 10.1111/bjh.16250
- By:
- Publication type:
- Article
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1340, doi. 10.1177/10781552211024727
- By:
- Publication type:
- Article
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 1, p. 74, doi. 10.1177/1078155219838316
- By:
- Publication type:
- Article
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 2, p. 374, doi. 10.1177/1078155214568582
- By:
- Publication type:
- Article
Thrombotic microangiopathy in the setting of human immunodeficiency virus infection: High incidence of severe thrombocytopenia.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 3, p. 342, doi. 10.1002/jca.21615
- By:
- Publication type:
- Article
Primary myelofibrosis in a patient with sickle cell disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 160, doi. 10.1002/ajh.26347
- By:
- Publication type:
- Article
Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074653
- By:
- Publication type:
- Article
The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071266
- By:
- Publication type:
- Article
MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3θ.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0050895
- By:
- Publication type:
- Article
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 9, p. 2119, doi. 10.1007/s00277-020-04179-z
- By:
- Publication type:
- Article
Isolated thrombocytopenia and liver function abnormalities characterizing an atypical presentation of thrombotic thrombocytopenic purpura.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4166, doi. 10.3390/cancers14174166
- By:
- Publication type:
- Article
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 21, p. 1814, doi. 10.1001/jama.2024.4783
- By:
- Publication type:
- Article
Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation.
- Published in:
- Molecular Cytogenetics (17558166), 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13039-019-0460-2
- By:
- Publication type:
- Article
Interferon-α-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy.
- Published in:
- Cancer (0008543X), 1998, v. 83, n. 9, p. 1938, doi. 10.1002/(SICI)1097-0142(19981101)83:9<1938::AID-CNCR9>3.0.CO;2-M
- By:
- Publication type:
- Article
Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.783744
- By:
- Publication type:
- Article
Rituximab Maintenance Therapy Until Progression After Rituximab and Chemotherapy Induction in Patients With Follicular Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 253, doi. 10.1016/j.clml.2012.12.011
- By:
- Publication type:
- Article
Normal full-term pregnancy in a patient with chronic myelogenous leukemia treated with α-interferon.
- Published in:
- American Journal of Hematology, 1991, v. 37, n. 1, p. 66, doi. 10.1002/ajh.2830370122
- By:
- Publication type:
- Article
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. 674, doi. 10.1016/j.clml.2023.05.002
- By:
- Publication type:
- Article
MDS-426: Cardiovascular Disease and Marrow Vascular Markers in Patients with Myeloid Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S350, doi. 10.1016/S2152-2650(21)01812-7
- By:
- Publication type:
- Article
MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S343, doi. 10.1016/S2152-2650(21)01798-5
- By:
- Publication type:
- Article
Poster: MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01429-4
- By:
- Publication type:
- Article
Poster: MDS-426: Cardiovascular Disease and Marrow Vascular Markers in Patients with Myeloid Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S229, doi. 10.1016/S2152-2650(21)01445-2
- By:
- Publication type:
- Article
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The OPTIC Study: A Multicenter, Randomized, Phase 2 Trial to Evaluate Three Starting Doses of Ponatinib With Response-Based Dose Reduction in Patients with Chronic Phase Chronic Myeloid Leukemia Resistant to Prior Tyrosine Kinase Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S228, doi. 10.1016/j.clml.2018.07.104
- By:
- Publication type:
- Article
KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL): Outcomes in Patients Who Were Treated with Prior Blinatumomab in ZUMA-3.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S184, doi. 10.1016/j.clml.2018.07.015
- By:
- Publication type:
- Article
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 245, doi. 10.1007/s00280-006-0367-6
- By:
- Publication type:
- Article
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 179, doi. 10.1007/s00280-006-0357-8
- By:
- Publication type:
- Article
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Impact of FLT3 -ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study.
- Published in:
- Biology (2079-7737), 2022, v. 11, n. 6, p. 916, doi. 10.3390/biology11060916
- By:
- Publication type:
- Article